Quote For Novo Nordisk A/S
Novo Nordisk A/S (NOVOb.CO) (Copenhagen Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
kr.322.75
24 Nov 2009
-2.20%
kr.330.00
kr.329.00
926,854
kr.329.00
kr.322.00
kr.333.75
kr.234.50
0.28
645,086
News
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Scheibye, Sten | Independent Chairman of the Board | 1,000,000 |
| Rebien Soerensen, Lars | President, Chief Executive Officer | 8,700,000 |
| Ando, Goran | Vice Chairman of the Board, Research and Development Facilitator | 600,000 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | kr.194,942.80 |
| Shares Outstanding (Mil.) | 590.74 |
| Float (Mil.) | 333.40 |
| Dividend Information | |
|---|---|
| Yield % | -- |
| Annual Dividend (kr. DKK) | 6.00 |
| Payout Ratio(TTM) % | 33.87 |
| Financial Strength | |
|---|---|
| Quick Ratio | 1.50 |
| Current Ratio | 2.40 |
| LT Debt/Equity | 2.76 |
| Total Debt/Equity | 3.42 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 18.64 |
| Price/Sales(TTM) | 3.85 |
| Price/Book(TTM) | 5.60 |
| Price/Cash Flow(TTM) | 14.63 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | kr.17.85 |
| Sales(TTM) | kr.83.08 |
| Book Value(MRQ) | kr.58.88 |
| Cash Flow(TTM) | kr.21.88 |
| Cash(MRQ) | kr.20.03 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 32.14 |
| Return on Assets(TTM) | 21.22 |
| Return on Investment(TTM) | 28.23 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 79.57 |
| Operating Margin(TTM) % | 29.82 |
| Profit Margin(TTM) % | 21.29 |
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 76.89 | +0.56% | 11/25 11:48 IST |
| Gold | 1175.2 | +0.80% | 11/25 11:28 IST |
